Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Multiple Sclerosis: HELP
Jeffrey A. Cohen
Based on 86 articles published since 2007
||||
Expertise Level
The expertise of Jeffrey A. Cohen ranks in the
  • Top 0.042%
  • ... of 52,846 published authors worldwide on Multiple Sclerosis
  • ... from 2007 through 2018
  • ... based on contributions to 86 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Cohen, J A   ·   Cohen, Jeffrey A   ·   Cohen, Jeffrey
Work Locations
Details
Most likely:    Cleveland Clinic   Contact    
2017
  • Department of Neurology, University of Bristol Southmead Hospital, Bristol BS10 5NB, UK. · Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI 53226, USA. · Scientific and Clinical Research Associates, LLC, Salisbury, CT 06068, USA. · Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 29053779
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. Electronic address: · Departments of Dermatology and Pathology, Cleveland Clinic, Cleveland, OH, USA. · Department of Pathology, (Section of Dermatopathology), The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 29055440
  • Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, USA. · Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Department of Neurology, University at Buffalo, Buffalo, NY, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206828
  • Department of Radiology, University of Michigan, Ann Arbor, Michigan. Electronic address: · Department of Radiology, University of Michigan, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Ann Arbor, Michigan. · Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas. · Department of Neurology, Cleveland Clinic, Mellen Center, Cleveland, Ohio. · Department of Neurology, University of Alabama, Birmingham, Alabama. · Department of Neurology, University of Virginia Health System, Charlottesville, Virginia. · Department of Neurology, University of Michigan, Ann Arbor, Michigan. · Pubmed 27932248
  • Biostatistics Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. · Neurological Clinic and Polyclinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital Basel, Basel, Switzerland. · Medical Image Analysis Center (MIAC), University Hospital Basel, Basel, Switzerland. · Neurological Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA. · Department of Radiology, VU University Medical Center, Amsterdam, Netherlands. · Department of Neurology, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany. · Novartis Pharma AG, Basel, Switzerland. · University of Siena, Siena, Italy. · Pubmed 27411701
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. · Department of Quantitative Health Sciences, Center for Outcomes Research and Evaluation, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. · Pubmed 27230791
  • Biogen, Cambridge, MA, USA. · Cleveland Clinic, Cleveland, OH, USA. · University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · University of Virginia, Charlottesville, VA, USA. · Department of Neurology, Medical Faculty, Heinrich- Heine University, Düsseldorf, Germany. · Charles University in Prague, Prague, Czech Republic. · Piedmont HealthCare, Huntersville, NC, USA. · National Hospital for Neurology and Neurosurgery, London, UK. · Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Danish Multiple Sclerosis Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Pubmed 27003945
2016
  • Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. Electronic address: · NeuroRx Research and Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Neurology, Milan, Italy. · Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Receptos Inc, Clinical Development, San Diego, CA, USA. · Neurology Center, Lodz, Poland. · Pubmed 26879276
  • Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. · Center for Neurological Disorders and the Regional MS Center at WFHC, Milwaukee, Wisconsin, USA. · Image Analysis Centre, VU University Medical Centre, Amsterdam, The Netherlands. · Department of Neurology, Vita-Salute San Raffaele University, Milan, Italy. · Department of Neurology, Heinrich Heine University, Düsseldorf, Germany. · Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Neurology and CRMBM CNRS6612, Aix Marseille Université, CHU La Timone, Marseille, France. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Biogen, 14 Cambridge Center, Cambridge, Massachusetts, USA. · Novartis Pharma AG, Basel, Switzerland. · Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital, Basel, Switzerland. · Pubmed 26111826
  • Lou Ruvo Center for Brain Health, Cleveland Clinic, 888 W. Bonneville Ave, Las Vegas, NV, 89106 USA. Electronic address: · Department of Epidemiology and Biostatistics, Case Western Reserve University, 10900 Euclid Ave, Cleveland, 44106 USA. · Department of Neurology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195 USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195 USA. · Pubmed 27919497
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundatio, 9500 Euclid Avenue/U10, Cleveland, OH, 44195 USA. Electronic address: · Department of Quantitative Health Sciences, Neurological Institute Center for Outcomes Research and Evaluation, Cleveland Clinic Foundation, 9500 Euclid Avenue/JJ3, Cleveland, OH, 44195 USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundatio, 9500 Euclid Avenue/U10, Cleveland, OH, 44195 USA. · Pubmed 27645360
2015
  • Department of Internal Medicine, University of Manitoba, Winnipeg, Canada/Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada · Department of Internal Medicine, University of Manitoba, Winnipeg, Canada. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Scientific and Clinical Review Associates, LLC, Salisbury, CT, USA. · Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 25538150
  • Department of Internal Medicine, University of Manitoba, Winnipeg, Canada/Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada · Department of Internal Medicine, University of Manitoba, Winnipeg, Canada. · Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Scientific and Clinical Review Associates, LLC, Salisbury, CT, USA. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Pubmed 25533302
  • Department of Internal Medicine, University of Manitoba, Winnipeg, Canada/Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada · Department of Internal Medicine, University of Manitoba, Winnipeg, Canada. · Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Scientific and Clinical Review Associates, LLC, Salisbury, CT, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA. · Pubmed 25533301
  • 1 Departments of Neurology, Ophthalmology and Population Health, New York University School of Medicine, NY 10016, USA. · 2 Queen Square MS Centre, UCL Institute of Neurology, London, WC1N 3BG, UK. · 3 Scientific and Clinical Review Associates, LLC, CT 06068, USA. · 4 Neurological Institute, Cleveland Clinic, OH 44195, USA · Pubmed 25433914
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio. · Functional Diagnostics, Research Institute of Traumatology and Orthopedics, Nizhniy Novgorod, Russian Federation. · Neurology Center Lodz, Lodz, Poland. · Lycalis sprl, Brussels, Belgium. · Department of Health Sciences, University of Genoa, Genoa, Italy. · Synthon BV, Nijmegen, the Netherlands. · Image Analysis Center, Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands. · Pubmed 26458034
  • From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · Pubmed 25632085
  • Mellen Center for MS Treatment and Research, Neurological institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 25896088
  • 1 Department of Neurology, School of Medicine, University of California, San Francisco, CA 94158, USA 2 Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Saga 849-8501, Japan. · 1 Department of Neurology, School of Medicine, University of California, San Francisco, CA 94158, USA. · 1 Department of Neurology, School of Medicine, University of California, San Francisco, CA 94158, USA 3 Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812-8582, Japan. · 4 John P. Hussman Institute for Human Genomics and The Dr John T Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, FL 33136, USA. · 5 Department of Neurology, Washington University School of Medicine, St. Louis, MO 63108, USA. · 6 Department of Neurology, New York University School of Medicine, New York, NY 10016, USA. · 7 Multiple Sclerosis Centre and The Sastry Foundation Advanced Imaging Laboratory, Department of Neurology, Wayne State University School of Medicine, Detroit, MI 48201, USA. · 8 Mellen Centre for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44195, USA. · 9 Centre for Public Health Genomics, University of Virginia, Charlottesville, VA 22908, USA. · 10 Department of Clinical Neurosciences, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, UK. · 1 Department of Neurology, School of Medicine, University of California, San Francisco, CA 94158, USA · Pubmed 25818868
2014
  • Division of Cardiovascular Medicine, University of Virginia Health System, P.O. Box 800158, Charlottesville, VA 22908-0466, USA. Electronic address: · St Michael׳s Hospital, 30 Bond Street, University of Toronto, Toronto, ON, Canada M5B 1W8. Electronic address: · Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Electronic address: · University of Chicago Medical Center, 5841 S. Maryland Ave, Chicago, IL 60637-1403, USA. Electronic address: · Novartis Pharma AG, CH-4056 Basel, Switzerland. Electronic address: · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936-1080, USA. Electronic address: · Novartis Pharma AG, CH-4056 Basel, Switzerland. Electronic address: · Neurology, Departments of Medicine, Clinical Research and Biomedicine, University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland. Electronic address: · Pubmed 26265275
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio. · Translational Neuroscience Facility, School of Medical Sciences, University of New South Wales, Sydney, Australia. · Department of Neurology, University of Rochester Medical Center, Rochester, New York. · Biogen Idec, Weston, Massachusetts. · Department of Neurology, Charles University, Prague, Czech Republic. · Department of Neurology, VU Medical Center, Amsterdam, the Netherlands. · Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio7currently with Biogen Idec, Weston, Massachusetts. · Pubmed 25178496
  • From The Daroff-Dell'Osso Laboratory (A.S., M.M.S., J.B.J., M.F.W.), Louis Stokes Veterans Affairs Medical Center; University Hospitals (A.S.); Case Western Reserve University (A.S., J.B.J., M.F.W.); and the Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic, Cleveland, OH. · From The Daroff-Dell'Osso Laboratory (A.S., M.M.S., J.B.J., M.F.W.), Louis Stokes Veterans Affairs Medical Center; University Hospitals (A.S.); Case Western Reserve University (A.S., J.B.J., M.F.W.); and the Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic, Cleveland, OH. · Pubmed 24907233
2013
  • Mellen Center, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA. Electronic address: · Pubmed 23294498
  • Mellen Center U-10, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 23632946
2012
  • Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 22516081
  • Mellen Center, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 23122652
2011
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 21520239
2010
  • Mellen Center, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 20089954
2009
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 19597083
  • Mellen Center U-10, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 19204263
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA. · Pubmed 19200869
2008
  • Mellen Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 18208877
2007
  • Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 17372130
2017
  • From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835403
  • From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835401
2016
  • From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted). · From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted). · Pubmed 27733571
  • From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · Pubmed 27590291
  • From the Departments of Internal Medicine (R.A.M.) and Community Health Sciences (R.A.M.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit (M.P.S.), Department of Health Sciences, University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · From the Departments of Internal Medicine (R.A.M.) and Community Health Sciences (R.A.M.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit (M.P.S.), Department of Health Sciences, University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · Pubmed 26888986
  • From the Departments of Internal Medicine (R.A.M., K.F.) and Community Health Sciences (R.A.M., N.R.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit, Department of Health Sciences (M.P.S.), University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · From the Departments of Internal Medicine (R.A.M., K.F.) and Community Health Sciences (R.A.M., N.R.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit, Department of Health Sciences (M.P.S.), University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · Pubmed 26865523
2015
  • Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, 9500 Euclid Avenue/U10, Cleveland, OH, 44195, USA, · Pubmed 26239599
  • 1Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 25271798
2014
  • From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · Pubmed 24975856
  • Mellen Center for Multiple Sclerosis Treatment & Research, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. · Pubmed 24762071
  • From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY; Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT; The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH; the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham; the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark; University College London Institute of Neurology (A.J.T.), UK; the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston; the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York; the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA; the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands; Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY; the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD; Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France; the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy; University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada; the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY; the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY; the Department of Neurology (L.K.), University Hospital, Basel, Switzerland; the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany; the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France; the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain; the Division of · Pubmed 24871874
  • From Novartis Pharma AG (G. Karlsson, P.H., W.C.), Basel, Switzerland; Novartis Pharmaceuticals Corporation (G.F., X.Z.), East Hanover, NJ; Motherisk Program (G. Koren), Hospital for Sick Children, Toronto, Canada; Neurological Institute (J.A.C.), Cleveland Clinic, OH; and Neurology and Department of Biomedicine (L.K.), University Hospital, Basel, Switzerland. · Pubmed 24463630
2013
  • Neurological Institute, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 23709211
2012
  • The Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 21888515
  • Mellen Center, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 23040960
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 22653659
2011
  • Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 21163434
2010
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, OH 44195, USA. · Pubmed 20170843
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue/U10, Cleveland, OH 44195, USA. · Pubmed 20549393
  • Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue/U10, Cleveland, OH 44195, USA. · Pubmed 21131915
2009
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44106, USA. · Pubmed 19667023
2008
  • Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 19068409
2007
  • Cleveland Clinic Foundation, Mellen Center U-10, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 17868019
Probable:    Miscellaneous cities in USA      
2017
  • a Mellen Center for Multiple Sclerosis Treatment and Research , Neurological Institute, Cleveland Clinic , Cleveland , OH , USA. · Pubmed 27756172
2016
  • a Mellen Center for Multiple Sclerosis Treatment and Research , Neurological Institute, Cleveland Clinic , Cleveland , OH , USA. · Pubmed 26800293
2015
  • Department of Internal Medicine, University of Manitoba, Canada/Department of Community Health Sciences, University of Manitoba, Health Sciences Center, Canada · Mellen Center for MS Treatment and Research, Cleveland Clinic, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Scientific and Clinical Review Associates, LLC, USA. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Department of Internal Medicine, University of Manitoba, Canada. · Pubmed 25623244
  • Department of Internal Medicine, University of Manitoba, Canada/Department of Community Health Sciences, University of Manitoba, Canada · Scientific and Clinical Review Associates, LLC, USA. · Mellen Center for MS Treatment and Research, Cleveland Clinic, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Department of Community Health Sciences, University of Manitoba, Canada. · Pubmed 25583845
  • Department of Internal Medicine, University of Manitoba, Canada/Department of Community Health Sciences, University of Manitoba, Canada · Department of Internal Medicine, University of Manitoba, Canada. · Mellen Center for MS Treatment and Research, Cleveland Clinic, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Scientific and Clinical Review Associates, LLC, USA. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Pubmed 25533300
  • Departments of Internal Medicine and Community Health Sciences, University of Manitoba, Canada · Departments of Internal Medicine and Community Health Sciences, University of Manitoba, Canada. · Mellen Center for MS Treatment and Research, Cleveland Clinic, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Scientific and Clinical Review Associates, LLC, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Pubmed 25533299
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA · Mellen Center for Multiple Sclerosis Treatment and Research/Neurological Institute Center for Outcomes Research and Evaluation/ Department of Quantitative Health Sciences, Cleveland Clinic, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA. · Biogen Idec./Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA. · Pubmed 25112816
2014
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, USA · Pubmed 25160120
  • Image Analysis Center, VU University Medical Center, The Netherlands · Image Analysis Center, VU University Medical Center, The Netherlands. · Novartis Pharma AG, Switzerland. · Novartis Pharmaceuticals Corporation, USA. · Neurological Institute, Cleveland Clinic Foundation, USA. · Pubmed 24812043
2014
Probable:    Vrije Universiteit Amsterdam      
2015
  • From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · Pubmed 25632085
2014
  • From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY; Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT; The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH; the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham; the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark; University College London Institute of Neurology (A.J.T.), UK; the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston; the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York; the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA; the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands; Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY; the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD; Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France; the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy; University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada; the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY; the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY; the Department of Neurology (L.K.), University Hospital, Basel, Switzerland; the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany; the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France; the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain; the Division of · Pubmed 24871874
2011
  • Department of Neurology, Free University, Amsterdam, the Netherlands. · Pubmed 21387374
2008
  • Department of Neurology, Free University Medical Center in Amsterdam, PO Box 4075, 1007 MB Amsterdam, The Netherlands. · Pubmed 18362273
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 86 total) written by Jeffrey A. Cohen about Multiple Sclerosis:

  • Cell-based therapeutic strategies for multiple sclerosis. 2017
  • Safety of monoclonal antibodies for the treatment of multiple sclerosis. 2017
  • Merkel cell carcinoma with fingolimod treatment for multiple sclerosis: A case report. 2017
  • Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. 2017
  • Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. 2017
  • Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. 2017
  • Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project. 2017
  • Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS. 2017
  • Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course. 2017
  • The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis. 2017
Show List of Full Article Records
Google Searches

Learn more about Jeffrey A. Cohen using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Cleveland Clinic
Miscellaneous cities in USA
Vrije Universiteit Amsterdam
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Cleveland Clinic
2017
  • Department of Neurology, University of Bristol Southmead Hospital, Bristol BS10 5NB, UK. · Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI 53226, USA. · Scientific and Clinical Research Associates, LLC, Salisbury, CT 06068, USA. · Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 29053779
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. Electronic address: · Departments of Dermatology and Pathology, Cleveland Clinic, Cleveland, OH, USA. · Department of Pathology, (Section of Dermatopathology), The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 29055440
  • Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, USA. · Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Department of Neurology, University at Buffalo, Buffalo, NY, USA. · Biogen, Cambridge, MA, USA. · National Multiple Sclerosis Society, New York, NY, USA. · Critical Path Institute, Tucson, AZ, USA. · Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA. · Pubmed 28206828
  • Department of Radiology, University of Michigan, Ann Arbor, Michigan. Electronic address: · Department of Radiology, University of Michigan, Ann Arbor, Michigan; Michigan Radiology Quality Collaborative, Ann Arbor, Michigan. · Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, Texas. · Department of Neurology, Cleveland Clinic, Mellen Center, Cleveland, Ohio. · Department of Neurology, University of Alabama, Birmingham, Alabama. · Department of Neurology, University of Virginia Health System, Charlottesville, Virginia. · Department of Neurology, University of Michigan, Ann Arbor, Michigan. · Pubmed 27932248
  • Biostatistics Unit, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy. · Neurological Clinic and Polyclinic, Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital Basel, Basel, Switzerland. · Medical Image Analysis Center (MIAC), University Hospital Basel, Basel, Switzerland. · Neurological Institute, The Cleveland Clinic Foundation, Cleveland, OH, USA. · Department of Radiology, VU University Medical Center, Amsterdam, Netherlands. · Department of Neurology, DKD Helios Klinik Wiesbaden, Wiesbaden, Germany. · Novartis Pharma AG, Basel, Switzerland. · University of Siena, Siena, Italy. · Pubmed 27411701
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. · Department of Quantitative Health Sciences, Center for Outcomes Research and Evaluation, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. · Pubmed 27230791
  • Biogen, Cambridge, MA, USA. · Cleveland Clinic, Cleveland, OH, USA. · University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada. · University of Virginia, Charlottesville, VA, USA. · Department of Neurology, Medical Faculty, Heinrich- Heine University, Düsseldorf, Germany. · Charles University in Prague, Prague, Czech Republic. · Piedmont HealthCare, Huntersville, NC, USA. · National Hospital for Neurology and Neurosurgery, London, UK. · Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Danish Multiple Sclerosis Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. · Pubmed 27003945
2016
  • Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. Electronic address: · NeuroRx Research and Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Neurology, Milan, Italy. · Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada. · Receptos Inc, Clinical Development, San Diego, CA, USA. · Neurology Center, Lodz, Poland. · Pubmed 26879276
  • Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. · Center for Neurological Disorders and the Regional MS Center at WFHC, Milwaukee, Wisconsin, USA. · Image Analysis Centre, VU University Medical Centre, Amsterdam, The Netherlands. · Department of Neurology, Vita-Salute San Raffaele University, Milan, Italy. · Department of Neurology, Heinrich Heine University, Düsseldorf, Germany. · Department of Neurology-Neuroimmunology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Neurology and CRMBM CNRS6612, Aix Marseille Université, CHU La Timone, Marseille, France. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Biogen, 14 Cambridge Center, Cambridge, Massachusetts, USA. · Novartis Pharma AG, Basel, Switzerland. · Departments of Medicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital, Basel, Switzerland. · Pubmed 26111826
  • Lou Ruvo Center for Brain Health, Cleveland Clinic, 888 W. Bonneville Ave, Las Vegas, NV, 89106 USA. Electronic address: · Department of Epidemiology and Biostatistics, Case Western Reserve University, 10900 Euclid Ave, Cleveland, 44106 USA. · Department of Neurology, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195 USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195 USA. · Pubmed 27919497
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundatio, 9500 Euclid Avenue/U10, Cleveland, OH, 44195 USA. Electronic address: · Department of Quantitative Health Sciences, Neurological Institute Center for Outcomes Research and Evaluation, Cleveland Clinic Foundation, 9500 Euclid Avenue/JJ3, Cleveland, OH, 44195 USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundatio, 9500 Euclid Avenue/U10, Cleveland, OH, 44195 USA. · Pubmed 27645360
2015
  • Department of Internal Medicine, University of Manitoba, Winnipeg, Canada/Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada · Department of Internal Medicine, University of Manitoba, Winnipeg, Canada. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Scientific and Clinical Review Associates, LLC, Salisbury, CT, USA. · Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 25538150
  • Department of Internal Medicine, University of Manitoba, Winnipeg, Canada/Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada · Department of Internal Medicine, University of Manitoba, Winnipeg, Canada. · Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Scientific and Clinical Review Associates, LLC, Salisbury, CT, USA. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Pubmed 25533302
  • Department of Internal Medicine, University of Manitoba, Winnipeg, Canada/Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada · Department of Internal Medicine, University of Manitoba, Winnipeg, Canada. · Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Scientific and Clinical Review Associates, LLC, Salisbury, CT, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA. · Pubmed 25533301
  • 1 Departments of Neurology, Ophthalmology and Population Health, New York University School of Medicine, NY 10016, USA. · 2 Queen Square MS Centre, UCL Institute of Neurology, London, WC1N 3BG, UK. · 3 Scientific and Clinical Review Associates, LLC, CT 06068, USA. · 4 Neurological Institute, Cleveland Clinic, OH 44195, USA · Pubmed 25433914
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio. · Functional Diagnostics, Research Institute of Traumatology and Orthopedics, Nizhniy Novgorod, Russian Federation. · Neurology Center Lodz, Lodz, Poland. · Lycalis sprl, Brussels, Belgium. · Department of Health Sciences, University of Genoa, Genoa, Italy. · Synthon BV, Nijmegen, the Netherlands. · Image Analysis Center, Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, the Netherlands. · Pubmed 26458034
  • From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · Pubmed 25632085
  • Mellen Center for MS Treatment and Research, Neurological institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 25896088
  • 1 Department of Neurology, School of Medicine, University of California, San Francisco, CA 94158, USA 2 Division of Neurology, Department of Internal Medicine, Saga University Faculty of Medicine, Saga, Saga 849-8501, Japan. · 1 Department of Neurology, School of Medicine, University of California, San Francisco, CA 94158, USA. · 1 Department of Neurology, School of Medicine, University of California, San Francisco, CA 94158, USA 3 Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Fukuoka 812-8582, Japan. · 4 John P. Hussman Institute for Human Genomics and The Dr John T Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, FL 33136, USA. · 5 Department of Neurology, Washington University School of Medicine, St. Louis, MO 63108, USA. · 6 Department of Neurology, New York University School of Medicine, New York, NY 10016, USA. · 7 Multiple Sclerosis Centre and The Sastry Foundation Advanced Imaging Laboratory, Department of Neurology, Wayne State University School of Medicine, Detroit, MI 48201, USA. · 8 Mellen Centre for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44195, USA. · 9 Centre for Public Health Genomics, University of Virginia, Charlottesville, VA 22908, USA. · 10 Department of Clinical Neurosciences, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0QQ, UK. · 1 Department of Neurology, School of Medicine, University of California, San Francisco, CA 94158, USA · Pubmed 25818868
2014
  • Division of Cardiovascular Medicine, University of Virginia Health System, P.O. Box 800158, Charlottesville, VA 22908-0466, USA. Electronic address: · St Michael׳s Hospital, 30 Bond Street, University of Toronto, Toronto, ON, Canada M5B 1W8. Electronic address: · Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. Electronic address: · University of Chicago Medical Center, 5841 S. Maryland Ave, Chicago, IL 60637-1403, USA. Electronic address: · Novartis Pharma AG, CH-4056 Basel, Switzerland. Electronic address: · Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936-1080, USA. Electronic address: · Novartis Pharma AG, CH-4056 Basel, Switzerland. Electronic address: · Neurology, Departments of Medicine, Clinical Research and Biomedicine, University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland. Electronic address: · Pubmed 26265275
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio. · Translational Neuroscience Facility, School of Medical Sciences, University of New South Wales, Sydney, Australia. · Department of Neurology, University of Rochester Medical Center, Rochester, New York. · Biogen Idec, Weston, Massachusetts. · Department of Neurology, Charles University, Prague, Czech Republic. · Department of Neurology, VU Medical Center, Amsterdam, the Netherlands. · Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio7currently with Biogen Idec, Weston, Massachusetts. · Pubmed 25178496
  • From The Daroff-Dell'Osso Laboratory (A.S., M.M.S., J.B.J., M.F.W.), Louis Stokes Veterans Affairs Medical Center; University Hospitals (A.S.); Case Western Reserve University (A.S., J.B.J., M.F.W.); and the Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic, Cleveland, OH. · From The Daroff-Dell'Osso Laboratory (A.S., M.M.S., J.B.J., M.F.W.), Louis Stokes Veterans Affairs Medical Center; University Hospitals (A.S.); Case Western Reserve University (A.S., J.B.J., M.F.W.); and the Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic, Cleveland, OH. · Pubmed 24907233
2013
  • Mellen Center, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA. Electronic address: · Pubmed 23294498
  • Mellen Center U-10, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 23632946
2012
  • Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 22516081
  • Mellen Center, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 23122652
2011
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 21520239
2010
  • Mellen Center, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 20089954
2009
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 19597083
  • Mellen Center U-10, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 19204263
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA. · Pubmed 19200869
2008
  • Mellen Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 18208877
2007
  • Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 17372130
2017
  • From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General Hospital in Prague, Czech Republic; Neuroimmunology and Multiple Sclerosis Research, Department of Neurology (S.S.), University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Sanofi (D.H.M., K.T., M.C.C., D.J., M.A.P.), Cambridge, MA; Envision Scientific Solutions (P.X.), Philadelphia, PA; Envision Scientific Solutions (R.J.H.), Sydney, NSW, Australia; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835403
  • From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · From the Department of Neurology and Center for Clinical Neuroscience (E.H.), First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic; NeuroRx Research (D.L.A.), Montréal; Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany; MS Clinic of Central Texas (E.J.F.), Central Texas Neurology Consultants, Round Rock; Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Neuroimmunology and Multiple Sclerosis Research (S.S.), Department of Neurology, University Hospital Zürich and University of Zürich, Switzerland; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; The University of British Columbia (A.T.), Vancouver, Canada; Department of Clinical Neurosciences (D.A.S.C., A.J.C.), University of Cambridge, UK; Sanofi (D.H.M., K.T., C.E.R., D.J., M.A.P.), Cambridge, MA; Evidence Scientific Solutions (R.J.H.), Sydney, NSW, Australia; and Evidence Scientific Solutions (P.X.), Philadelphia, PA. M.A.P. is currently affiliated with Wave Life Sciences, Cambridge, MA. · Pubmed 28835401
2016
  • From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted). · From Queen Mary University of London (G.G.), Barts and The London School of Medicine, UK; Mellen Center (J.A.C.), Cleveland Clinic, OH; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology and Center for Clinical Neuroscience (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Sanofi Genzyme (D.H.M., S.L.L., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (S.M.K.), Philadelphia, PA (at the time the work was conducted). · Pubmed 27733571
  • From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · From NeuroRx Research (D.L.A.) and Department of Neurology and Neurosurgery (D.L.A.), Montréal Neurological Institute, McGill University, Québec, Canada; Department of Biomedical Engineering (E.F.) and Mellen Center (J.A.C.), Cleveland Clinic, OH; Zagreb Medical School and University Hospital Center (V.V.B.), Croatia; Department of Clinical Neurosciences (A.J.C., D.A.S.C.), University of Cambridge, UK; Queen Mary University of London (G.G.), Barts and the London School of Medicine, UK; Department of Neurology and Center for Neuropsychiatry (H.-P.H.), Heinrich-Heine University, Düsseldorf, Germany; Department of Neurology (E.H.), First Medical Faculty, Charles University in Prague, Czech Republic; Department of Neurology (K.W.S.), Medical University of Łódź, Poland; Clinical Centre Kragujevac (M.S.), Clinic of Neurology, Serbia; Brigham and Women's Hospital Center for Neurologic Diseases (H.L.W.), Boston, MA; Sanofi Genzyme (S.L.L., D.H.M., M.A.P.), Cambridge, MA; and Evidence Scientific Solutions (D.R.T.), Horsham, West Sussex, UK. Dr. Panzara is currently with Wave Life Sciences, Cambridge, MA. · Pubmed 27590291
  • From the Departments of Internal Medicine (R.A.M.) and Community Health Sciences (R.A.M.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit (M.P.S.), Department of Health Sciences, University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · From the Departments of Internal Medicine (R.A.M.) and Community Health Sciences (R.A.M.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit (M.P.S.), Department of Health Sciences, University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · Pubmed 26888986
  • From the Departments of Internal Medicine (R.A.M., K.F.) and Community Health Sciences (R.A.M., N.R.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit, Department of Health Sciences (M.P.S.), University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · From the Departments of Internal Medicine (R.A.M., K.F.) and Community Health Sciences (R.A.M., N.R.), University of Manitoba, Winnipeg, Canada; Icahn School of Medicine at Mount Sinai (A.M.), New York, NY; Biostatistic Unit, Department of Health Sciences (M.P.S.), University of Genova, Italy; Faculty of Brain Sciences (A.T.), University College London, UK; University of California San Francisco (E.W.); Department of Basic Medical Sciences, Neurosciences and Sense Organs (M.T.), University of Bari, Italy; St. Michael's Hospital (P.O.), Toronto, Canada; Scientific and Clinical Review Associates, LLC (S.R.), Salisbury, CT; and Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · Pubmed 26865523
2015
  • Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, 9500 Euclid Avenue/U10, Cleveland, OH, 44195, USA, · Pubmed 26239599
  • 1Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 25271798
2014
  • From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · Pubmed 24975856
  • Mellen Center for Multiple Sclerosis Treatment & Research, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. · Pubmed 24762071
  • From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY; Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT; The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH; the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham; the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark; University College London Institute of Neurology (A.J.T.), UK; the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston; the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York; the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA; the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands; Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY; the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD; Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France; the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy; University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada; the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY; the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY; the Department of Neurology (L.K.), University Hospital, Basel, Switzerland; the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany; the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France; the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain; the Division of · Pubmed 24871874
  • From Novartis Pharma AG (G. Karlsson, P.H., W.C.), Basel, Switzerland; Novartis Pharmaceuticals Corporation (G.F., X.Z.), East Hanover, NJ; Motherisk Program (G. Koren), Hospital for Sick Children, Toronto, Canada; Neurological Institute (J.A.C.), Cleveland Clinic, OH; and Neurology and Department of Biomedicine (L.K.), University Hospital, Basel, Switzerland. · Pubmed 24463630
2013
  • Neurological Institute, The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44195, USA. · Pubmed 23709211
2012
  • The Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA. · Pubmed 21888515
  • Mellen Center, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 23040960
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. · Pubmed 22653659
2011
  • Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. · Pubmed 21163434
2010
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, OH 44195, USA. · Pubmed 20170843
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue/U10, Cleveland, OH 44195, USA. · Pubmed 20549393
  • Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue/U10, Cleveland, OH 44195, USA. · Pubmed 21131915
2009
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44106, USA. · Pubmed 19667023
2008
  • Mellen Center for MS Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 19068409
2007
  • Cleveland Clinic Foundation, Mellen Center U-10, 9500 Euclid Avenue, Cleveland, OH 44195, USA. · Pubmed 17868019
Miscellaneous cities in USA
2017
  • a Mellen Center for Multiple Sclerosis Treatment and Research , Neurological Institute, Cleveland Clinic , Cleveland , OH , USA. · Pubmed 27756172
2016
  • a Mellen Center for Multiple Sclerosis Treatment and Research , Neurological Institute, Cleveland Clinic , Cleveland , OH , USA. · Pubmed 26800293
2015
  • Department of Internal Medicine, University of Manitoba, Canada/Department of Community Health Sciences, University of Manitoba, Health Sciences Center, Canada · Mellen Center for MS Treatment and Research, Cleveland Clinic, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Scientific and Clinical Review Associates, LLC, USA. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Department of Internal Medicine, University of Manitoba, Canada. · Pubmed 25623244
  • Department of Internal Medicine, University of Manitoba, Canada/Department of Community Health Sciences, University of Manitoba, Canada · Scientific and Clinical Review Associates, LLC, USA. · Mellen Center for MS Treatment and Research, Cleveland Clinic, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Department of Community Health Sciences, University of Manitoba, Canada. · Pubmed 25583845
  • Department of Internal Medicine, University of Manitoba, Canada/Department of Community Health Sciences, University of Manitoba, Canada · Department of Internal Medicine, University of Manitoba, Canada. · Mellen Center for MS Treatment and Research, Cleveland Clinic, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Scientific and Clinical Review Associates, LLC, USA. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Pubmed 25533300
  • Departments of Internal Medicine and Community Health Sciences, University of Manitoba, Canada · Departments of Internal Medicine and Community Health Sciences, University of Manitoba, Canada. · Mellen Center for MS Treatment and Research, Cleveland Clinic, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA. · Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark. · Department of Biostatistics, University of Alabama at Birmingham, USA. · Scientific and Clinical Review Associates, LLC, USA. · Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy. · Pubmed 25533299
  • Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA · Mellen Center for Multiple Sclerosis Treatment and Research/Neurological Institute Center for Outcomes Research and Evaluation/ Department of Quantitative Health Sciences, Cleveland Clinic, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA. · Biogen Idec./Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA. · Pubmed 25112816
2014
  • Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, USA. · Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, USA · Pubmed 25160120
  • Image Analysis Center, VU University Medical Center, The Netherlands · Image Analysis Center, VU University Medical Center, The Netherlands. · Novartis Pharma AG, Switzerland. · Novartis Pharmaceuticals Corporation, USA. · Neurological Institute, Cleveland Clinic Foundation, USA. · Pubmed 24812043
2014
Vrije Universiteit Amsterdam
2015
  • From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · Pubmed 25632085
2014
  • From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY; Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT; The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH; the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham; the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark; University College London Institute of Neurology (A.J.T.), UK; the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston; the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York; the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA; the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands; Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY; the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD; Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France; the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy; University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada; the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY; the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY; the Department of Neurology (L.K.), University Hospital, Basel, Switzerland; the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany; the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France; the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain; the Division of · Pubmed 24871874
2011
  • Department of Neurology, Free University, Amsterdam, the Netherlands. · Pubmed 21387374
2008
  • Department of Neurology, Free University Medical Center in Amsterdam, PO Box 4075, 1007 MB Amsterdam, The Netherlands. · Pubmed 18362273
University of Basel
2015
  • From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · From the Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Image Analysis Center (F.B.), VU Medical Centre, Amsterdam, the Netherlands; Departments of Medicine and Clinical Research, Neurology (L.K., T.S.) and Radiology (T.S.), Division of Neuroradiology, University Hospital, Basel, Switzerland; Novartis Pharma AG (D.A.H., A.d.V., P.v.R.), Basel, Switzerland; Oxford PharmaGenesis Ltd. (J.R.B.), Tubney, Oxford, UK; Novartis Pharmaceuticals Corporation (G.F.), East Hanover, NJ; and Neurological Institute (J.A.C.), Cleveland Clinic, OH. · Pubmed 25632085
2014
  • From the Corinne Goldsmith Dickenson Center for Multiple Sclerosis (F.D.L., A.E.M.), Icahn School of Medicine at Mount Sinai, New York, NY; Scientific and Clinical Review Associates, LLC (S.C.R.), Salisbury, CT; The Mellen Center for MS Treatment and Research (J.A.C., R.J.F., R.A.R.), Cleveland Clinic, OH; the Department of Biostatistics (G.R.C.), University of Alabama at Birmingham; the Danish Multiple Sclerosis Center (P.S.S.), Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark; University College London Institute of Neurology (A.J.T.), UK; the Department of Neurology (J.S.W., J.A.L.), University of Texas Health Sciences Center, Houston; the Department of Neurology (L.J.B.), New York University Langone Medical Center, New York; the Division of Neurology (B. Banwell), The Children's Hospital of Philadelphia, PA; the Departments of Radiology and Nuclear Medicine (F.B.) and Neurology (C.H.P.), VU Medical Center, Amsterdam, the Netherlands; Research Programs Department (B. Bebo), National Multiple Sclerosis Society, New York, NY; the Department of Neurology (P.A.C.), The Johns Hopkins Hospital, Baltimore, MD; Fédération de Neurologie (M.C.), CHU Hôpital Purpan, Toulouse, France; the Department of Neurology (G.C.), Scientific Institute San Raffaele, University Vita-Salute San Raffaele, Milan, Italy; University of Ottawa and the Ottawa Hospital Research Institute (M.S.F.), Canada; the Department of Neurology (A.D.G.), University of Rochester Medical Center, NY; the Departments of Neurology, Radiology and Neuroscience (M.I.), Mount Sinai School of Medicine, New York, NY; the Department of Neurology (L.K.), University Hospital, Basel, Switzerland; the Department of Neurology (B.C.K.), Heinrich-Heine-University, Düsseldorf, Germany; the Department of Neurology (C.L.), Salpêtrière Hospital, UPMC, Paris, France; the Department of Neurology-Neuroimmunology (X.M.), Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain; the Division of · Pubmed 24871874
  • From Novartis Pharma AG (G. Karlsson, P.H., W.C.), Basel, Switzerland; Novartis Pharmaceuticals Corporation (G.F., X.Z.), East Hanover, NJ; Motherisk Program (G. Koren), Hospital for Sick Children, Toronto, Canada; Neurological Institute (J.A.C.), Cleveland Clinic, OH; and Neurology and Department of Biomedicine (L.K.), University Hospital, Basel, Switzerland. · Pubmed 24463630
Case Western Reserve University
2014
  • From The Daroff-Dell'Osso Laboratory (A.S., M.M.S., J.B.J., M.F.W.), Louis Stokes Veterans Affairs Medical Center; University Hospitals (A.S.); Case Western Reserve University (A.S., J.B.J., M.F.W.); and the Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic, Cleveland, OH. · From The Daroff-Dell'Osso Laboratory (A.S., M.M.S., J.B.J., M.F.W.), Louis Stokes Veterans Affairs Medical Center; University Hospitals (A.S.); Case Western Reserve University (A.S., J.B.J., M.F.W.); and the Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic, Cleveland, OH. · Pubmed 24907233
2014
  • From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · Pubmed 24975856
2012
  • National Center for Regenerative Medicine, Case Western Reserve University, Cleveland, OH 44106, USA. · Pubmed 22642335
Veterans Health System
2014
  • From The Daroff-Dell'Osso Laboratory (A.S., M.M.S., J.B.J., M.F.W.), Louis Stokes Veterans Affairs Medical Center; University Hospitals (A.S.); Case Western Reserve University (A.S., J.B.J., M.F.W.); and the Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic, Cleveland, OH. · From The Daroff-Dell'Osso Laboratory (A.S., M.M.S., J.B.J., M.F.W.), Louis Stokes Veterans Affairs Medical Center; University Hospitals (A.S.); Case Western Reserve University (A.S., J.B.J., M.F.W.); and the Mellen Center for Multiple Sclerosis Treatment and Research (J.A.C.), Neurological Institute, Cleveland Clinic, Cleveland, OH. · Pubmed 24907233
2014
  • From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · From the Department of Neurology (D.N.B.), Oregon Health & Science University and Multiple Sclerosis Center of Excellence West, Veterans Affairs Medical Center, Portland; and the Mellen Center for MS Treatment and Research (J.A.C.), Cleveland Clinic, OH. · Pubmed 24975856
44 Other Locations Show
Yearly article counts 010915124864783
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.